Molecular Formula | C17H19N3O3S |
Molar Mass | 345.42 |
Density | 1.37±0.1 g/cm3(Predicted) |
Boling Point | 600.0±60.0 °C(Predicted) |
Specific Rotation(α) | D20 -155° (c = 0.5 in chloroform) |
Flash Point | 316.663°C |
Vapor Presure | 0mmHg at 25°C |
pKa | 8.50±0.10(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
Refractive Index | 1.669 |
Physical and Chemical Properties | Esomeprazole (Esomeprazole) (S)? Omeprazole, molecular weight 345.41600, density 1.37g/cm3, boiling point 600°C at 760mmHg, flash point 316.7°C, refractive index 1.669, vapor pressure 0mmHg at 25°C, A white or off-white lyophilized cake or powder. It can effectively inhibit gastric acid secretion and is often used in the treatment of diseases associated with gastric acid secretion disorder. |
HS Code | 29339900 |
obtained from omeprazole resolution.
AstraZeneca pharmaceutical company, UK, was first launched in the UK in September 2000. Proton pump inhibitors. The pure levorotatory isomer of Omeprazole. For the initial and long-term treatment of gastroesophageal reflux disease (GORD), including erosive reflux esophagitis (including erosive esophagitis), can be used for long-term maintenance treatment of esophagitis and prevention of GORD recurrence, and symptomatic treatment of GORD's disease. Eradication of Helicobacter pylori in combination with antibiotics, treatment of duodenal ulcer caused by Helicobacter pylori, and prevention of recurrence of peptic ulcer associated with Helicobacter pylori.
This product is 5-methoxy-2-[(S)-[(4-methoxy-3, 5-dimethyl-2-pyridyl) methyl] thionyl]-1H-benzimidazole sodium salt. Based on water and solvent-free, containing not less than 98.0%.
take this product 2.0g, add methanol 100ml to dissolve, immediately according to UV-visible spectrophotometry (General rule 0401), at 440nm and 650nm Wavelength determination, the absorbance shall not be greater than 0.05.
take 2.0g of this product, add 100mn of water to dissolve it, and measure it according to law (General rule 0631). The pH value should be 10.3~11.3.
take an appropriate amount of this product, precision weighing, and add mobile phase A to dissolve and quantitatively dilute to make A solution containing about 0.2mg per 1 ml, as A test solution (using A new precision quantity to take appropriate amount, diluted with mobile phase A to make A solution containing about 0.2ug per 1 ml, as A sensitivity solution. Silica gel bonded with eighteen alkyl Silanes (Microspher C18, 0512mm x mm , 3um or performance equivalent column) was used as the filler according to the determination by high performance liquid chromatography (general rule); the mobile phase A was water-phosphate buffer (pH 7.6) (containing 0.0052mol of sodium dihydrogen phosphate and 0.032mol of sodium dihydrogen phosphate per 1000ml)-acetonitrile (80:10:10); using acetonitrile-phosphate buffer (pH 7.6)-Water (80:1:19) as mobile Phase B, the detection wavelength was 302mn, and the linear gradient elution was carried out as follows. Take appropriate amount of omeprazole reference substance and impurity I reference substance respectively, add mobile phase A to dissolve and dilute to make A mixed solution containing about 0.02 mg per 1 ml, and inject 20u1 into human liquid chromatograph, the retention time of the omeprazole peak is 14-19 minutes, and the degree of separation of the omeprazole peak from the impurity I peak should be greater than 2.5. The sensitivity solution 20u1 was injected into the liquid chromatograph, and the chromatogram was recorded. The signal to noise ratio of the main component peak height should be greater than 10. Then, 200 of the sample solution was accurately measured and injected into the liquid chromatograph, and the chromatogram was recorded for 30 minutes. If there are impurity peaks in the chromatogram of the test solution, according to the peak area normalization method, impurity I shall not exceed 0.2%, impurity II (relative retention time is about 0.21) and impurity III (relative retention time is about 1.10) shall not exceed 0.1%, other single impurities shall not exceed 0.1%, and the total amount of impurities shall not exceed 0.5%.
take this product, add phosphate buffer (pH 11.0)(every 1000ml containing sodium phosphate 0.0028mol and disodium hydrogen phosphate 0.Ollmol) dissolve and quantitatively dilute to make a solution containing about 0.32mg per 1 ml, take 2ml precisely, put it in a 20ml measuring flask, dilute it to the scale with water, shake well, and use it as a test solution. According to the determination of high performance liquid chromatography (General rule 0512), using a1-acid glycoprotein bonded silica gel as filler; Phosphate buffer (pH 6.0) (containing sodium dihydrogen phosphate 0.0175mol and disodium hydrogen phosphate 0.0025mol per 1000ml)-Acetonitrile (85:15) as mobile phase, the detection wavelength was 302nm. Take about 18mg of omeprazole reference, put it in a 100ml measuring flask, add 5ml of methanol to dissolve, dilute it to the scale with the above phosphate buffer (pH 11.0), shake well, and take 2ml with precision, place the flask in 100ml, dilute to the scale with water, shake well, and inject into the liquid chromatograph in the order of enantiomeric peak and esomeprazole peak, the retention time of the esomeprazole peak is 4 to 5 minutes, and the degree of separation between the two peaks should be greater than 3. The sample solution 20u1 was accurately measured and injected into human liquid chromatograph, and the chromatogram was recorded. Calculated according to the peak area normalization method, the ruler-enantiomer should not exceed 0.5%.
take about 0.25g of this product, weigh it precisely, put it in a 20ml headspace bottle, add 2ml of N ,N-dimethylacetamide precisely, seal it, shake it well, and use it as a test solution; another 38mg of toluene was added to a 100ml measuring flask, diluted with N ,IV-dimethylacetamide to the scale, and then shaken; 62mg of acetone, 38mg of methanol and 25mg of acetonitrile were added to the flask, add 10ml of the above toluene solution to a 100ml measuring flask, dilute with IV,N-dimethylacetamide to the scale, shake well, take 2ml of the sample, and place it in a 20ml head-space flask, precision weight: 0.25g, Seal, shake, as a control solution. According to the determination method of residual solvent (General Principle 0861 second method), the capillary column with 6% cyanopropylphenyl-94% dimethyl polysiloxane (or similar polarity) as the stationary liquid is the column; The column temperature is 40°C, maintain 5 minutes, at a rate of 10°C per minute to 100°C, and then at a rate of 30°C per minute to 230°C, maintain 3 minutes; The injection temperature is 200°C, the detector temperature was 280°C; The headspace bottle equilibration temperature was 10°C and the equilibration time was 20 minutes. Take the reference solution into the headspace, record the chromatogram, the separation degree between the peaks of each component should be greater than 3.0. Then take the reference solution and the test solution into the headspace respectively, record the chromatogram
.
Figure, calculated by peak area according to external standard method. Toluene residues should not exceed 0.03%, acetone, methanol and acetonitrile residues should be in accordance with the provisions.
take this product, according to the moisture determination method (General 0832 first method 1), the water content shall not exceed 1.0%.
take this product l. Add 4ml of 25% magnesium sulfate in dilute sulfuric acid solution to the Crucible, mix well, slowly burn to complete charring, burn at 700-800°C for 1 hour, cool, and dissolve the residue with 10ml of dilute hydrochloric acid, add 1 drop of phenolphthalein indicator solution, add concentrated ammonia solution Dropwise until the solution is pink, add glacial acetic acid Dropwise until the pink color disappears, add 0.5 of glacial acetic acid, filter, rinse filter with water, combine filtrate and wash solution, diluted with water to 20ml, inspection according to law (General Principles 0821 The first law), containing heavy metals shall not exceed 20 parts per million.
take this product about 0.3g, precision weighing, add new boiling cold water 50ml to dissolve, according to the potential titration method (General 0701), with hydrochloric acid titration solution (0.lmol/L) titration. Each 1 ml of hydrochloric acid titration solution (0.1 mol/L) corresponds to 36.74mg of C17H18N303SNa.
proton pump inhibitors.
light shielding, sealed storage.
This product is a sterile lyophilized product of esomeprazole sodium. The content of esomeprazole sodium shall be 97.0% ~ 109.0% of the labeled amount calculated as esomeprazole (C17H18N3O3S).
This product is a white or off-white mass or powder.
Same as esomeprazole sodium.
40mg (based on C17HI9N303S)
light shielding, closed storage.